Abstract: A method for inducing differentiated cells into mesenchymal stem cells (MSCs), and combinations of regulatory targets thereof. The method includes performing a directional induction on the differentiated cells to prepare the mesenchymal stem cells. The directional induction includes treating cells by inhibiting the TGF-? signal pathway, inhibiting the activity of PKC, activating the WNT/?-catenin signal pathway and activating the cAMP signal pathway. By regulating corresponding signal pathways and/or enzymatic activities by stages, the differentiated cells are induced into the mesenchymal stem cells.
Type:
Grant
Filed:
November 6, 2017
Date of Patent:
June 13, 2023
Assignee:
Yunnan Jici Institute for Regenerative Medicine Co., Ltd.
Abstract: A method for inducing differentiated cells into mesenchymal stem cells (MSCs), and combinations of regulatory targets thereof. The method includes performing a directional induction on the differentiated cells to prepare the mesenchymal stem cells. The directional induction includes treating cells by inhibiting the TGF-? signal pathway, inhibiting the activity of PKC, activating the WNT/?-catenin signal pathway and activating the cAMP signal pathway. By regulating corresponding signal pathways and/or enzymatic activities by stages, the differentiated cells are induced into the mesenchymal stem cells.
Type:
Application
Filed:
November 6, 2017
Publication date:
November 14, 2019
Applicant:
Yunnan Jici Institute for Regenerative Medicine Co., Ltd.